The North America market for anticoccidial drugs is estimated to grow from $815.5 million in 2015 to $980 Million by 2020 at a CAGR of 3.4%. With the ban on consumption of antibiotics as a source of animal feed and the upsurge in antibiotic resistant microbes has reduced the growth of the antibiotic market, nevertheless the rising incidence of coccidiosis over the time and its control on the overall cost to benefit ratio for the meat industry has increased the growth potential of anticoccidials drug market.
Browse market data tables and in-depth TOC of the North America Anticoccidial Drugs Market to 2021 @ http://www.marketdataforecast.com/market-reports/north-america-anticoccidial-drugs-market-22/
Coccidiosis caused by coccidian protozoa, is a parasitic infection of the intestinal tract of animals. The disease feasts from one animal to another by any contact with infected faeces or consumption of infected tissue. It infects a wide variety of animals, such as cattle, poultry species, pigs and sheep. It can be responsible for devastating mislay in meat production. To overcome this problem, anticoccidial drugs play an important role in the prevention and treatment of coccidiosis.
Growing demand for meat proteins is forcing the farmers, mainly in the developed countries to use various antibiotics for maintaining a quality production. Further, the trend of owning companion animals in these nations is increasing the expenditure on antibiotics, driving the North American anticoccidial market.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/north-america-anticoccidial-drugs-market-22/request-sample
The North America anticoccidial drugs market is classified based on various types of animals and by type of drugs. The animal segment is sub-categorised into poultry, swine, fish, cattle and companion animals. The companion animal is further segmented into dogs and cats. The livestock segment has a greater potential compares to others. In addition to this, the market is also analysed on the basis of drug type into antibiotic anticoccidials, Ionophore anticoccidials and chemical derivative anticoccidials.
Furthermore, on the basis of geography, the North America market is analysed under various regions namely, USA and Canada. North America leads the global anticoccidial drugs market owing to increased preventive usage of anticoccidials in animal feed. It contributes to around 24% of the worldwide market for anticoccidial drugs with U.S.A holding the largest market share for anticoccidial drugs followed by Canada.
Currently, the major players in the industry are facing complications with the rising incidences of microbial resistance build-up to anticoccidial drugs and government regulations in developed regions, which is compelling them to invest in emerging markets. Some of the key players operating in the market are Bayer Health care, Zoetis, Elanco, Merial, Merck Animal Healthcare, Virbac, Ceva Santé Animale, Boehringer Ingelheim Animal Health, Novartis Animal Healthcare and Smartvet Inc.
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases